VCU Health System Authority; changes relating to board of directors and chief executive officer.
Summary
HB2161 revises the governance structure of the Virginia Commonwealth University Health System Authority. The bill reduces the board of directors from 21 members to 17, lowers the number of appointed members from 19 to 15, and changes the mix of appointing authorities and physician-faculty representation. It also extends board terms from three years to four years, changes the limit on consecutive service, and updates board leadership rules, including when and how the board elects a chair and vice-chair.
The bill also changes how the Authority’s chief executive officer is selected and removed. Under the substitute, the CEO is to be chosen jointly by the Authority’s board and the VCU board of visitors at a joint meeting, with a fallback process involving committees from each board and, if needed, a final decision by the university president. The bill clarifies that the CEO must work full time for the Authority and sets a transition rule allowing the current CEO to remain in place until a successor is selected under the new process.
In practical terms, the bill amends §§ 23.1-2402 and 23.1-2403 of the Code of Virginia, affecting the composition, appointment process, and governance procedures of the VCU Health System Authority. It also makes the State and Local Government Conflict of Interests Act applicable to board members and Authority employees, and preserves compensation and expense reimbursement rules for board service. The changes apply to board appointments made on or after July 1, 2025.
The overall sentiment reflected in the voting history is strongly supportive. The bill advanced through committee and floor votes with unanimous or near-unanimous approval in both chambers, indicating broad agreement on the need to update governance and leadership provisions for the Authority. The final recorded action shows some later-day division in the House, but the bill’s formal committee and passage votes were overwhelmingly favorable.
There is little evidence of substantive opposition in the available record, but the main policy issue is institutional control: the bill shifts board size and appointment balance, and it creates a more structured shared decision-making process for selecting the CEO between the Authority and VCU’s board of visitors. Those changes could be viewed as improving oversight and coordination, while also raising questions about how much autonomy the Authority should have relative to the university and its leadership.
Impact
The bill amends Virginia Code §§ 23.1-2402 and 23.1-2403 to restructure the VCU Health System Authority’s board, alter appointment and term rules, and revise the process for selecting and removing the Authority’s chief executive officer. It also applies conflict-of-interest rules to board members and employees, and it establishes a delayed effective application for new board terms and a transition provision for the current CEO.
Sentiment
The bill appears to have received broad bipartisan support, with unanimous committee votes and unanimous House and Senate passage votes recorded in the legislative history. The available context suggests general agreement that the Authority’s governance and leadership provisions needed updating, and there is no transcript evidence of significant public controversy.
Contention
The central point of contention, to the extent one exists, is governance control over the VCU Health System Authority—specifically, how many board members should serve, who appoints them, and whether the Authority or the university should have the dominant role in choosing the CEO. The bill’s new joint-selection process and fallback decision-making by committees and the university president suggest an effort to balance Authority independence with university oversight. No specific opposing arguments are included in the available transcripts.